Optimizing RNA manufacturing for rapid RNA therapeutics development

In this webinar, we will discuss key topics related to RNA therapeutics, optimization of mRNA stability and functionality, and the potentials of circular RNA as a novel class of therapeutics. Dr. Fengmei Pi will also present an optimal in-vitro transcription (IVT) manufacturing workflow for high-performing mRNA production, and address stability and functionality concerns.

Furthermore, we will explore the unique features and advantages of circRNAs as a novel class of therapeutics, and the potential of circRNA to overcome the short half-life limitation of linear mRNA, opening new possibilities for RNA-based therapies.